ANTICOAGULANT DOSING CONVERSIONS; Conversion of DABIGATRAN ETEXILATE: Switching from DABIGATRAN to WARFARIN • Adjust starting time of warfarin based on CrCl as follows: ...

If you've been diagnosed with a deep venous thrombosis (DVT), you can expect at least three months of continued anticoagulants, or blood-thinning medications, such as warfarin, after you leave the ...

A world wide team of researchers addressed one of the trickiest drugs to prescribe -- the blood-thinner warfarin. Each patient's optimal dose varies widely, is hard to predict, and is crucial for ...

Findings from a recent study suggests that clinical and genetic factors affecting warfarin dose requirements differ by race. The study is published in the journal Blood.Blood.

Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse events compared with ...

Incorporating genetic information into clinical algorithms may help clinicians better determine optimal doses of warfarin for patients who require doses higher and lower than the mean, according ...

Genetically guided warfarin dosing lowers risk of some adverse events Date: March 20, 2017 Source: American College of Cardiology Summary: Using genetic testing to help personalize doses of ...

Patients using warfarin for oral anticoagulant therapy need to be frequently monitored because of warfarin's narrow therapeutic range and the large variation in dose requirements among patients ...

A world wide team of researchers addressed one of the trickiest drugs to prescribe -- the blood-thinner warfarin. Each patient's optimal dose varies widely, is hard to predict, and is crucial for ...

A total of 455 patients were recruited, with 227 randomly assigned to the genotype-guided group and 228 assigned to the control group. The mean percentage of time in the therapeutic range was 67.4 ...

† Excluding children with target INR above 3. ‡ Results presented as means. § Genotyping for variant alleles *2 and *3 only except in validation dataset, which also included test for *5, *6 ...